Glycotope GmbH Revenue and Competitors
Estimated Revenue & Valuation
- Glycotope GmbH's estimated annual revenue is currently $4.8M per year.
- Glycotope GmbH's estimated revenue per employee is $155,000
Employee Data
- Glycotope GmbH has 31 Employees.
- Glycotope GmbH grew their employee count by -3% last year.
Glycotope GmbH's People
| Name | Title | Email/Phone |
|---|
Glycotope GmbH Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $36.9M | 238 | 9% | N/A | N/A |
#2 | $33.7M | 174 | -10% | $521.9M | N/A |
#3 | $52.4M | 338 | 15% | N/A | N/A |
#4 | $162.7M | 1219 | 33% | N/A | N/A |
#5 | $43.2M | 279 | 7% | N/A | N/A |
#6 | $1.1M | 7 | N/A | N/A | N/A |
#7 | $24.2M | 156 | 10% | N/A | N/A |
#8 | $19.7M | 127 | 8% | N/A | N/A |
#9 | $21.2M | 137 | 12% | $347.1M | N/A |
#10 | $18.3M | 118 | 7% | $197.4M | N/A |
What Is Glycotope GmbH?
Glycotope, founded in Berlin in 2000, is a clinical stage immuno-oncology company built on world-leading glycobiology expertise. A set of our highly innovative clinical and pre-clinical projects with focus on oncology/immuno-oncology are available for partnering. The Company has a mature and growing pipeline of proprietary cancer therapies. Our innovative GlycoExpress® technology enables the generation of high quality oncology and non-oncology candidates with fully human glycosylation improving activity, drug characteristics and side effect profiles. The GlycoBody platform generates highly specific mAbs against carbohydrate epitopes found only on tumor cells. In addition, our capabilities in early-stage research and development provide a wide range of services for biopharmaceutical companies incl. glycan analytics (N- and O-glycans) as well as a whole range of protein analytics, USP and DSP process development, assay development in immune oncology as well as clinical immunomonitoring (http://www.glycotope.com/biopharmaceuticals-services/).
keywords:N/A
N/A
Total Funding
31
Number of Employees
$4.8M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Glycotope GmbH News
Berlin, Germany, 08 April, 2022 Glycotope GmbH, a biotechnology company developing antibodies against proteins carrying tumor-specific...
Other Companies in Berlin
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.2M | 31 | -3% | N/A |
#2 | $6.2M | 31 | -35% | N/A |
#3 | $15M | 31 | -28% | N/A |
#4 | $3.6M | 31 | N/A | N/A |
#5 | $3.5M | 31 | 3% | N/A |